Table 1. Summary of antibodies used in the present study.
| Antibody | Source | Cat. Number | Dilution used |
|---|---|---|---|
| CD1a | Dako, Glostrup, Denmark | M0721 | 1:100 |
| MHC-Cll (DR) | Dako, Glostrup, Denmark | M0704 | 1:100 |
| CD80 | Pharmingen, San Diego, CA, USA | 33514X | 1:50 |
| CD83 | Pharmingen, San Diego, CA, USA | 556910 | 1:40 |
| Langerin | Novocastra, Benton Lane, UK | VPL 552 | 1:100 |
| Anti-mouse Ig-POX | Amersham Bioscience, Buckinghamshire, UK | NA931 | 1:250 |
| Anti-DV2 | P. Kouri Tropical Medicine Institute, Havana, Cuba | 1:100 | |
| Anti-rNS1 | Laboratory of Virology, Department of Biomedicine, CINVESTAV-IPN | 1:50 |